Latest filing published 17 Jun 2025 for KALA BIO, Inc.. Read the official filing
No signal scores available.
C. Daniel Myers discloses dealings in KALA BIO, Inc. to SEC (Form 4). Between 31 May 2023 and 15 June 2025, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 17 June 2025 came the latest disclosure, a share grant in KALA BIO, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations